John R. Strauss

892 total citations
18 papers, 686 citations indexed

About

John R. Strauss is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, John R. Strauss has authored 18 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in John R. Strauss's work include Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Receptor Mechanisms and Signaling (4 papers). John R. Strauss is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Receptor Mechanisms and Signaling (4 papers). John R. Strauss collaborates with scholars based in United States, Japan and Canada. John R. Strauss's co-authors include Gloria Y. Kwei, Wei Tang, George A. Doss, Ralph A. Stearns, David C. Evans, Matthew P. Braun, Xiaoyan Chu, Jocelyn Yabut, Regina W. Wang and Shuet-Hing Lee Chiu and has published in prestigious journals such as Journal of Applied Physiology, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

In The Last Decade

John R. Strauss

18 papers receiving 663 citations

Peers

Countries citing papers authored by John R. Strauss

Since Specialization

Citations

This map shows the geographic impact of John R. Strauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Strauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Strauss more than expected).

Fields of papers citing papers by John R. Strauss

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Strauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Strauss. The network helps show where John R. Strauss may publish in the future.

Co-authorship network of co-authors of John R. Strauss

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Strauss. A scholar is included among the top collaborators of John R. Strauss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Strauss. John R. Strauss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Characterization of Multidrug Resistance 1a/P-Glycoprotein Knockout Rats Generated by Zinc Finger Nucleases 2011 ·Molecular Pharmacology ·Xiaoyan Chu, Zuo‐Feng Zhang, Jocelyn Yabut, Sarah McCue Horwitz, John M. Levorse, Xiangqing Li, Lei Zhu, (unknown), (unknown), John R. Strauss, Xiaofang Li, (unknown), Jasminka Dragovic, (unknown), Raymond Evers, Myung K. Shin	35
2	Effect of enalapril on thein vitroandin vivopeptidyl cleavage of a potent VLA-4 antagonist 2007 ·Xenobiotica ·(unknown), (unknown), (unknown), (unknown), Carol Keohane, John R. Strauss, Stella Vincent	8
3	Effect of the anticoagulant ethylenediamine tetra-acetic acid (EDTA) on the estimation of pharmacokinetic parameters: A case study with tigecycline and ciprofloxacin 2007 ·Xenobiotica ·(unknown), (unknown), (unknown), John R. Strauss, (unknown), (unknown), Wei Tang	11
4	Characterization of Mice Lacking the Multidrug Resistance Protein Mrp2 (Abcc2) 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Xiaoyan Chu, John R. Strauss, (unknown), Jing Li, Deborah J. Newton, Xiaoxin Cai, Regina W. Wang, Jocelyn Yabut, Dylan P. Hartley, David C. Evans, Raymond Evers	105
5	Validation of Rat Endometriosis Model by Using Raloxifene as a Positive Control for the Evaluation of Novel SERM Compounds 2005 ·Journal of Investigative Surgery ·(unknown), Xun Shen, Isabella Capodanno, Marcie J. Donnelly, Judy Fenyk‐Melody, (unknown), Christian Nunes da Silva, John R. Strauss, (unknown)	52
6	EVIDENCE FOR THE BIOACTIVATION OF ZOMEPIRAC AND TOLMETIN BY AN OXIDATIVE PATHWAY: IDENTIFICATION OF GLUTATHIONE ADDUCTS IN VITRO IN HUMAN LIVER MICROSOMES AND IN VIVO IN RATS 2005 ·Drug Metabolism and Disposition ·Qing Chen, George A. Doss, (unknown), (unknown), Yui S. Tang, Matthew P. Braun, (unknown), John R. Strauss, Regina W. Wang, Ralph A. Stearns, David C. Evans, Thomas A. Baillie, Wei Tang	38
7	Effect of Quinidine on the 10-Hydroxylation of R-Warfarin: Species Differences and Clearance Projection 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Qing Chen, Eugene Tan, John R. Strauss, Zhoupeng Zhang, Judith E. Fenyk-Melody, Catherine Booth-Genthe, Thomas H. Rushmore, Ralph A. Stearns, David C. Evans, Thomas A. Baillie, Wei Tang	2
8	DIFFERENCES IN THE PHARMACOKINETICS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR AGONISTS IN GENETICALLY OBESE ZUCKER AND SPRAGUE-DAWLEY RATS: IMPLICATIONS OF DECREASED GLUCURONIDATION IN OBESE ZUCKER RATS 2004 ·Drug Metabolism and Disposition ·Misook Kim, Sui Wang, Zhongzhou Shen, Christopher J. Kochansky, John R. Strauss, Ronald B. Franklin, Stella Vincent	28
9	THE METABOLIC DISPOSITION OF APREPITANT, A SUBSTANCE P RECEPTOR ANTAGONIST, IN RATS AND DOGS 2004 ·Drug Metabolism and Disposition ·(unknown), Brian J. Dean, George A. Doss, Zhen Wang, Cornelis E. C. A. Hop, (unknown), Paul E. Finke, Albert J. Robichaud, Minghua Zhang, Bonnie Wang, John R. Strauss, Paul Cunningham, William P. Feeney, Ronald B. Franklin, Thomas A. Baillie, Shuet-Hing Lee Chiu	31
10	Metabolism and disposition of gemfibrozil in Wistar and multidrug resistance-associated protein 2-deficient TR⁻rats 2003 ·Xenobiotica ·(unknown), (unknown), John R. Strauss, Isabella Capodanno, (unknown), Judith E. Fenyk-Melody, Ronald B. Franklin, Stella Vincent	16
11	Design and synthesis of potent, orally bioavailable dihydroquinazolinone inhibitors of p38 MAP kinase 2003 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Luping Liu, Sangita B. Patel, James V. Pivnichny, Giovanna Scapin, Suresh B. Singh, Cornelis E. C. A. Hop, Zhen Wang, John R. Strauss, Patricia M. Cameron, E.A. Nichols, Stephen J. O’Keefe, Edward A. O’Neill, Dennis M. Schmatz, Cheryl D. Schwartz, Chris M. Thompson, Dennis M. Zaller, James B. Doherty	66
12	Identification of Metabolites of a Substance P (Neurokinin 1 Receptor) Antagonist in Rat Hepatocytes and Rat Plasma 2002 ·Drug Metabolism and Disposition ·Cornelis E. C. A. Hop, Yanfeng Wang, Sanjeev Kumar, Maria Victoria Silva Elipe, Conrad E. Raab, Dennis Dean, Grace K. Poon, (unknown), John R. Strauss, Shuet‐Hing Lee Chiu, Neil R. Curtis, Jason Elliott, Ute Gerhard, Karen L Locker, Denise Morrison, Russell J. Mortishire‐Smith, Steven R. Thomas, Alan P. Watt, David C. Evans	6
13	Metabolism of a Thiazole Benzenesulfonamide Derivative, a Potent and Selective Agonist of the Human β3-Adrenergic Receptor, in Rats: Identification of a Novel Isethionic Acid Conjugate 2002 ·Drug Metabolism and Disposition ·Wei Tang, Ralph A. Stearns, Randall R. Miller, Jason S. Ngui, Robert J. Mathvink, Ann E. Weber, Gloria Y. Kwei, John R. Strauss, Carol Keohane, George A. Doss, Shuet-Hing Lee Chiu, Thomas A. Baillie	8
14	The Pharmacokinetics of a Thiazole Benzenesulfonamide β3-Adrenergic Receptor Agonist and Its Analogs in Rats, Dogs, and Monkeys: Improving Oral Bioavailability 2002 ·Drug Metabolism and Disposition ·Ralph A. Stearns, Randy R. Miller, Wei Tang, Gloria Y. Kwei, (unknown), Robert J. Mathvink, Elizabeth M. Naylor, (unknown), Vincent J. Colandrea, Ann E. Weber, Adria Colletti, John R. Strauss, Carol Keohane, William P. Feeney, Susan A. Iliff, Shuet‐Hing Lee Chiu	8
15	Urinalysis of atrazine exposure in farm pesticide applicators 2000 ·Toxicology and Industrial Health ·Melissa J. Perry, David C. Christiani, John Mathew, David C. Degenhardt, (unknown), John R. Strauss, William C. Sonzogni	26
16	Studies on Cytochrome P-450-Mediated Bioactivation of Diclofenac in Rats and in Human Hepatocytes: Identification of Glutathione Conjugated Metabolites 1999 ·Drug Metabolism and Disposition ·Wei Tang, Ralph A. Stearns, Stelvio M. Bandiera, Yong Zhang, Conrad E. Raab, Matthew P. Braun, Dennis Dean, Jianmei Pang, Kwan Leung, George A. Doss, John R. Strauss, Gloria Y. Kwei, Thomas H. Rushmore, Shuet-Hing Lee Chiu, Thomas A. Baillie	139
17	Disposition of Ivermectin and Cyclosporin A in CF-1 Mice Deficient in mdr1a P-Glycoprotein 1999 ·Drug Metabolism and Disposition ·Gloria Y. Kwei, Raúl Álvaro, Qing‐Hui Chen, Howard J. Jenkins, (unknown), Carol Keohane, (unknown), John R. Strauss, (unknown), (unknown), Todd R. Pippert, Diane R. Umbenhauer	100
18	Renal clearance and plasma protein binding of oxytetracycline in man 1960 ·Journal of Applied Physiology ·Samuel Kaplan, (unknown), John R. Strauss	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact